KLK3 and Familial prostate cancer: Prostate cancer, the second most frequent cancer and the fifth leading cause of cancer-specific mortality among men worldwide (1), is increasingly being detected with serum prostate-specific antigen (PSA) screening, especially the localized ones (2).